AnalysisNews

EOCN today

$1.78-$0.04 (-1.98%)close Nov 20, 2026

Trend

DailyDowntrend (confirmed)

4 hourDescending Triangle

1 hourStrong Bearish

15 minStrong Bearish

5 minConsolidating

Daily trend turns up above $3.48

Key levels

Resistance$2.98

Resistance$2.30

Latest news & SEC filings

ProductEocene and Barcode Nanotech advance tumor-targeting Aramchol formulation development

ProductEocene: Galmed and Barcode Nanotech make preclinical nanoparticle Aramchol for liver, GI tumor fibrosis

ProductEocene Ltd. launches CG-100 commercially in Greece and Cyprus

All EOCN news →

About Galmed Pharmaceuticals

Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company based in Israel. It is developing Aramchol, an oral drug candidate, initially for NASH and liver fibrosis and now also for oncological indications. The company is also exploring cardiometabolic programs and has no approved products or in-house manufacturing, relying on third parties.

Based on the company's 20-F filed Mar 31, 2026.

·

EOCN (EOCN)

$1.78-0.04 (-1.98%)
WATCHLISTGrade: C+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
2.072.352.642.921.78Oct 20Oct 28Nov 5Nov 13
High1.96
Low1.78
Open1.84
Volume8K
Avg Vol8K
VWAP1.86
30d High3.21
30d Low1.78
30d Chg-44.54%

What Is the Price Target for EOCN?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $2.20Upside: +0.0%Confidence: 20%Method: No Coverage

Is EOCN a Buy or Sell Right Now?

51
Investability Score
WATCHLIST12-18 months

Test your own strategy on EOCN

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on EOCN with SEPT’s own market data.

Start Free Trial →

Is EOCN Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

5

Moat Score

NONE

0/9

Piotroski Score

N/A

Altman Z-Score

What Is Smart Money Doing with EOCN?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

EOCN Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

N/A

FCF Growth YoY

N/A%

Revenue Trend

UNKNOWN

Dark Pool Trades for EOCN

PREVIEW

Recent off-exchange (dark pool) prints for EOCN: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
19:49:34$1.802,250$$4KBUY
19:11:52$1.852,000$$4KBUY
18:29:20$1.951,010$$2KBUY
18:15:55$1.911,030$$2KSELL
17:43:32$1.901,139$$2KBUY

5 dark pool trades shown · $$14K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for EOCN (EOCN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

EOCN — frequently asked questions

What is EOCN stock price today?

EOCN (EOCN) is at $1.78, down 1.98% (-$0.04) at the Nov 20, 2026 close.

Why is EOCN stock moving today?

Latest EOCN news — Nov 17, 2026: Eocene and Barcode Nanotech advance tumor-targeting Aramchol formulation development · Nov 16, 2026: Eocene: Galmed and Barcode Nanotech make preclinical nanoparticle Aramchol for liver, GI tumor fibrosis

Did EOCN beat earnings?

EOCN last reported on Sep 2, 2026: EPS -$2.86 vs -$3.12 expected — a beat of 8.3%.

What are EOCN support and resistance levels?

Resistance: $2.30, $2.98, $3.48.

What are insiders doing with EOCN?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on EOCN?

Nov 17, 2026: Eocene and Barcode Nanotech advance tumor-targeting Aramchol formulation development · Nov 16, 2026: Eocene: Galmed and Barcode Nanotech make preclinical nanoparticle Aramchol for liver, GI tumor fibrosis · Nov 11, 2026: Eocene Ltd. launches CG-100 commercially in Greece and Cyprus